These studies revealed that AML samples with high PDK1 expression were significantly enriched for leukemic stem cell and hematopoietic stem cell signatures, while AMLs with the lowest PDK1 expression were significantly enriched for terms “oxidative phosphorylation” and “NADH dehydrogenase complex” (Fig. 2d). Here, PDK1 is linked to acute myeloid leukemia.